Literature DB >> 34134646

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population.

Ahmad Faudzi Yusoff1, Zatil Zahidah Mohd Sharani2, Chee Cheong Kee3, Nuur Hafizah Md Iderus2, Ahmed Syahmi Syafiq Md Zamri2, Tharmarajah Nagalingam4, Mohd Safrin Mohamad Bashaabidin2, Wan Abdul Hannan Wan Ibadullah2, Sumarni Mohd Ghazali2, Ainur Yusniza Yusof5, Yee Ming Ching5, Nurhanani Mohamed Nor5, Balqis Kamarudin5, Norazah Ahmad6, Masita Arip5.   

Abstract

BACKGROUND: Despite high childhood immunization coverage, sporadic cases of diphtheria have been reported in Malaysia in recent years. This study aims to evaluate the seroprevalence of diphtheria among the Malaysian population.
METHODS: A total of 3317 respondents age 2 years old to 60 years old were recruited in this study from August to November 2017. Enzyme-linked immunosorbent assay (ELISA) was used to measure the level of IgG antibody against the toxoid of C. diphtheriae in the blood samples of respondents. We classified respondent antibody levels based on WHO definition, as protective (≥0.1 IU/mL) and susceptible (< 0.1 IU/mL) to C. diphtheriae infection.
RESULTS: Among the 3317 respondents, 57% were susceptible (38.1% of children and 65.4% of adults) and 43% (61.9% of children and 34.6% of adults) had protective antibody levels against diphtheria. The mean antibody level peaked among individuals aged 1-2 years old (0.59 IU/mL) and 6-7 years old (0.64 IU/mL) but generally decreased with age, falling below 0.1 IU/mL at around 4-6 years old and after age 20 years old. There was a significant association between age [Children: χ2 = 43.22(df = 2),p < 0.001)], gender [Adults: χ2 = 5.58(df = 1),p = 0.018] and ethnicity [Adults: χ2 = 21.49(df = 5),p = 0.001] with diphtheria toxoid IgG antibody level.
CONCLUSIONS: About 57% of the Malaysian population have inadequate immunity against diphtheria infection. This is apparently due to waning immunity following childhood vaccination without repeated booster vaccination in adults. Children at age 5-6 years old are particularly vulnerable to diphtheria infection. The booster vaccination dose normally given at 7 years should be given earlier, and an additional booster dose is recommended for high-risk adults.

Entities:  

Keywords:  Diphtheria; ELISA; Immunization; Seroprevalence; Toxoid IgG antibodies

Year:  2021        PMID: 34134646     DOI: 10.1186/s12879-021-06285-3

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  10 in total

1.  The seroprevalence of diphtheria among adults in Izmir-Turkey.

Authors:  Sema Alp Cavus; Vildan Avkan Oguz; Ayse Yuce
Journal:  Vaccine       Date:  2007-02-15       Impact factor: 3.641

2.  The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.

Authors:  W J Edmunds; R G Pebody; H Aggerback; S Baron; G Berbers; M A Conyn-van Spaendonck; H O Hallander; R Olander; P A Maple; H E Melker; P Olin; F Fievret-Groyne; C Rota; S Salmaso; A Tischer; C von-Hunolstein; E Miller
Journal:  Epidemiol Infect       Date:  2000-08       Impact factor: 2.451

3.  Susceptibility to diphtheria in adults: prevalence and relationship to gender and social variables.

Authors:  H Völzke; K M Kloker; A Kramer; L Guertler; M Dören; S E Baumeister; W Hoffmann; U John
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

4.  Serologic immunity to diphtheria and tetanus in the United States.

Authors:  Geraldine M McQuillan; Deanna Kruszon-Moran; Adamadia Deforest; Susan Y Chu; Melinda Wharton
Journal:  Ann Intern Med       Date:  2002-05-07       Impact factor: 25.391

5.  Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: nationwide population-based survey, 2010.

Authors:  Nino Khetsuriani; Katherina Zakikhany; Shamsiddin Jabirov; Nargis Saparova; Pavel Ursu; Kathleen Wannemuehler; Steve Wassilak; Androulla Efstratiou; Rebecca Martin
Journal:  Vaccine       Date:  2013-07-13       Impact factor: 3.641

6.  Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination.

Authors:  Mine Durusu Tanriover; Canan Soyler; Sibel Ascioglu; Mustafa Cankurtaran; Serhat Unal
Journal:  Eur J Intern Med       Date:  2014-05-09       Impact factor: 4.487

7.  Diphtheria antitoxin levels in the Netherlands: a population-based study.

Authors:  H E de Melker; G A Berbers; N J Nagelkerke; M A Conyn-van Spaendonck
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

8.  Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.

Authors:  Aleksandra A Zasada; Waldemar Rastawicki; Natalia Rokosz; Marek Jagielski
Journal:  BMC Infect Dis       Date:  2013-11-19       Impact factor: 3.090

Review 9.  How sex and age affect immune responses, susceptibility to infections, and response to vaccination.

Authors:  Carmen Giefing-Kröll; Peter Berger; Günter Lepperdinger; Beatrix Grubeck-Loebenstein
Journal:  Aging Cell       Date:  2015-02-26       Impact factor: 9.304

Review 10.  Sex differences in vaccine-induced humoral immunity.

Authors:  Stephanie Fischinger; Carolyn M Boudreau; Audrey L Butler; Hendrik Streeck; Galit Alter
Journal:  Semin Immunopathol       Date:  2018-12-13       Impact factor: 9.623

  10 in total
  1 in total

1.  The evaluation of anti-diphtheria toxoid antibodies in healthy population in Kon Tum, Vietnam: a population-based study.

Authors:  Tuan Van Le; Van Thi Tuyet Nguyen; Quan Hoang Nguyen; Tram Thi Thu Nguyen; Thuy Thi Ngoc Duong; Trang Thi Thuy Ly; Thanh Ngoc Pham; Vuong Loc Nguyen; Chien Chinh Vien
Journal:  IJID Reg       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.